State Street Corp Immutep LTD Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.09 $970 - $1,529	-495 Reduced 0.89%	55,053 $112,000
Q1 2022 May 16, 2022	BUY	$2.3 - $3.61 $5,681 - $8,916	2,470 Added 4.65%	55,548 $152,000
Q4 2021 Feb 14, 2022	BUY	$3.09 - $4.81 $3,022 - $4,704	978 Added 1.88%	53,078 $174,000
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.39 $165,157 - $228,718	52,100 New	52,100 $202,000

2.28M

6.7K

114K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $168M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.